rs2075783
Positions:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The ENST00000523004.1(GM2A):c.*294A>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.271 in 1,589,246 control chromosomes in the GnomAD database, including 62,073 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.23 ( 4856 hom., cov: 32)
Exomes 𝑓: 0.28 ( 57217 hom. )
Consequence
GM2A
ENST00000523004.1 3_prime_UTR
ENST00000523004.1 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.13
Genes affected
GM2A (HGNC:4367): (ganglioside GM2 activator) This gene encodes a small glycolipid transport protein which acts as a substrate specific co-factor for the lysosomal enzyme beta-hexosaminidase A. Beta-hexosaminidase A, together with GM2 ganglioside activator, catalyzes the degradation of the ganglioside GM2, and other molecules containing terminal N-acetyl hexosamines. Mutations in this gene result in GM2-gangliosidosis type AB or the AB variant of Tay-Sachs disease. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 5-151267219-A-C is Benign according to our data. Variant chr5-151267219-A-C is described in ClinVar as [Benign]. Clinvar id is 1234926.Status of the report is criteria_provided_single_submitter, 1 stars.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.377 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GM2A | NM_000405.5 | c.427-77A>C | intron_variant | ENST00000357164.4 | NP_000396.2 | |||
GM2A | NM_001167607.3 | c.413-273A>C | intron_variant | NP_001161079.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GM2A | ENST00000523004.1 | c.*294A>C | 3_prime_UTR_variant | 2/2 | 1 | ENSP00000430541.1 | ||||
GM2A | ENST00000357164.4 | c.427-77A>C | intron_variant | 1 | NM_000405.5 | ENSP00000349687.3 |
Frequencies
GnomAD3 genomes AF: 0.226 AC: 34317AN: 152084Hom.: 4849 Cov.: 32
GnomAD3 genomes
AF:
AC:
34317
AN:
152084
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.276 AC: 396094AN: 1437044Hom.: 57217 Cov.: 29 AF XY: 0.277 AC XY: 198415AN XY: 715446
GnomAD4 exome
AF:
AC:
396094
AN:
1437044
Hom.:
Cov.:
29
AF XY:
AC XY:
198415
AN XY:
715446
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.226 AC: 34330AN: 152202Hom.: 4856 Cov.: 32 AF XY: 0.230 AC XY: 17143AN XY: 74398
GnomAD4 genome
AF:
AC:
34330
AN:
152202
Hom.:
Cov.:
32
AF XY:
AC XY:
17143
AN XY:
74398
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
919
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 19, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at